2012 ©
             Publication
Journal Publication
Research Title Metformin suppresses cholangiocarcinoma cell migration/invasion in association with inhibition of mTOR and FAK pathways 
Date of Distribution 27 September 2018 
Conference
     Title of the Conference The 77th Annual Meeting of the Japanese Cancer Association 
     Organiser The Japanese Cancer Association 
     Conference Place Osaka International Convention Center 
     Province/State Osaka, JAPAN 
     Conference Date 27 September 2018 
     To 30 September 2018 
Proceeding Paper
     Volume 2018 
     Issue
     Page 84 
     Editors/edition/publisher  
     Abstract Metformin suppresses cholangiocarcinoma cell migration/invasion in association with inhibition of mTOR and FAK pathways Jaroon Wandee1, Auemduan Prawan1,2, Laddawan Senggunprai1,2, Sarinya Kongpetch1,2, Veerapol Kukongviriyapa1,2,* 1 Dept. Pharm., Faculty of Med., Khon Kaen Univ., Thailand 2 Cholangiocarcinoma Res. Insti., Khon Kaen Univ, Thailand *Corresponding author Cancer metastasis is one of the hallmarks of aggressive cancer which correlates with the poor prognosis of patients. Cholangiocarcinoma (CCA) is an aggressive malignancy with poor prognosis. Metformin (Met), a first-line antidiabetic drug, has been suggested to reduce risk of some cancers. The present study, we found that Met inhibited migration in CCA cells, KKU-100 and KKU-M156, as assessed by wound healing assay. Met also suppressed cell invasion of KKU-452 and KKU-M156 cells by transwell chamber assay. Cisplatin, a standard drug treatment in CCA, used alone or in combination with Met exhibited antiproliferation, but Cis showed modest effects on migration and invasion. The antimigration and antiinvasion effects of Met may be related to the suppression of mTOR and FAK signalings. The role of FAK in migration was affirmed by using PF573228, a selective FAK inhibitor. PF573228 markedly inhibited cell migration in CCA cells similar to Met. These results provide an evidence that Met may be an effective agent for suppression of cancer metastasis. Acknowledgement. This work was supported by grant-in-aid from Faculty of Medicine, Khon Kaen University, Thailand.  
Author
567070012-1 Mr. JAROON WANDEE [Main Author]
Medicine Doctoral Degree

Peer Review Status มีผู้ประเมินอิสระ 
Level of Conference นานาชาติ 
Type of Proceeding Abstract 
Type of Presentation Oral 
Part of thesis true 
Presentation awarding true 
     Award Title Travel grant 
     Type of award รางวัลด้านวิชาการ วิชาชีพ 
     Organiser The Japanese Cancer Association 
     Date of awarding 27 กันยายน 2561 
Attach file
Citation 0